OxyContin Maker Pays New York $75,000, Tightens Marketing Of It Opioid Drugs
(August 24, 2015, 9:23 AM EDT) -- NEW YORK — OxyContin maker Purdue Pharma will pay New York state a $75,000 penalty, tighten promotion of its opioid drugs and disclose financial relationships with a pain management website under an “assurance of discontinuance,” the state Attorney General’s Office announced Aug. 20 (In the Matter of Purdue Pharma L.P., Assurance No. 15-151, N.Y. A.G.).
(Assurance of discontinuance available. Document #28-150903-005P.)
In the assurance, Purdue Pharma agrees to strengthen its Abuse and Diversion Detection program by implementing additional measures to ensure that the company and its...